Ken Trester

Ken Trester

Ken Trester isn’t just another “options educator.” He’s a pro who has been trading options since the first exchanges opened in 1973.

Ken is widely quoted in publications such as Technical Analysis of Stocks & Commodities and Barron’s. He has earned considerable respect as a financial analyst and a highly sought lecturer at investment seminars throughout the United States.

Ken has an MBA and has also worked as a stockbroker, an investment manager and as a computer science professor at Golden West College in Huntington Beach, California, where he taught a wildly popular course on stock options trading.

Recent Articles

Sirius XM is Rising as Earnings Approach

This morning, I am recommending a bullish trade on Sirius XM Holdings, Inc. (NASDAQ:SIRI).

Johnson & Johnson Could Turn Around After its Strong Earnings

After its last earnings report, Johnson & Johnson (NYSE:JNJ) looks like a good target for a cheap ratio call debit spread.

Profit on Gold With a Position on Gold Miners

This morning, I'm recommending a ratio call debit spread on the VanEck Vectors Gold Miners ETF (NYSEARCA:GDX).

Kidney Dialysis Stocks are a Profitable Healthcare Bet

This morning, I am recommending a bullish trade on Baxter International Inc. (NYSE:BAX),  the renal and hospital product provider.

Profit From Bed Bath & Beyond’s Post-Earnings Drop

This morning, I am recommending a bearish trade on Bed Bath & Beyond Inc. (NASDAQ:BBBY).

Profit From the Push Into Gold With Newmont Goldcorp

This morning, I am recommending a bullish trade on Newmont Goldcorp Corporation (NYSE:NEM), the gold, copper, silver, zinc and lead producer.

Take Big Profits When this Financial ETF Retests Support

This morning, I am recommending a bearish trade on the Financial Select Sector SPDR Fund (NYSEARCA:XLF).

Profit From the U.S.-China Trade Truce With this JD.com Trade

This morning, I am recommending a bullish trade on JD.com, Inc. (NASDAQ:JD).

Protect Your Portfolio With a Cheap Semiconductor Play

This morning, I am recommending a bearish trade on Micron Technology, Inc. (NASDAQ:MU).

This Pharmaceutical Company is Oversold and Starting to Recover

This morning, I am recommending a bullish trade on AbbVie, Inc. (NYSE:ABBV), the biopharmaceutical company.